A phase Ia/Ib clinical trial testing the combination of sotorasib with the Aurora A kinase VIC-1911 is being conducted in patients with locally advanced or metastatic NSCLC harboring the KRAS G12C mutation (NCT05374538). Here, KRAS is linked to non-small cell lung carcinoma.